The global pulmonary arterial hypertension market size was valued at US$ 5.4 Billion in 2023, and is projected to reach US$ 12.7 Billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period from 2023 to 2033.This growth is driven by the increasing prevalence of cardiovascular diseases, rising geriatric populations, and advancements in PAH...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek